Medpace Holdings (MEDP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Medpace Holdings (MEDP) last issued guidance on July 22, 2026 for fiscal year 2026. The company guided earnings per share in the range of $17.25 - $17.95, compared to a consensus EPS estimate of $17.07. Medpace Holdings also guided revenue in the range of $2.81B - $2.88B for the period.
Compared to prior guidance, Medpace Holdings raised its EPS outlook from a previous range of $16.68 - $17.5. On the revenue side, the company raised its revenue forecast from a prior range of $2.75B - $2.85B.
Medpace Holdings has issued 18 guidance updates between October 24, 2022 and July 22, 2026. During this period, the company raised its outlook 14 times, reflecting management's growing confidence in business performance.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $3.99 | $3.87 | $4.21 | $3.54 |
| Actual | $4.25 | $4.28 | $4.67 | $3.86 |
| Surprise | +6.52% | +10.6% | +10.9% | +9.04% |
| Revenue | ||||
| Estimate | $687.8M | $696.3M | $687.0M | $640.8M |
| Actual | $707.3M | $706.6M | $708.5M | $659.9M |
| Surprise | +2.85% | +1.48% | +3.12% | +2.99% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $4.44 | $4.68 | $4.48 | $4.64 |
| Revenue | ||||
| Consensus | $713.2M | $719.1M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 22, 2026 | $4.25 | $3.99 | 6.52 % |
| Q1 | Apr 22, 2026 | $4.28 | $3.87 | 10.6 % |
| Q4 | Feb 9, 2026 | $4.67 | $4.21 | 10.9 % |
| Q3 | Oct 22, 2025 | $3.86 | $3.54 | 9.04 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 22, 2026 | $707.33M | $687.76M | 2.85 % |
| Q1 | Apr 22, 2026 | $706.60M | $696.28M | 1.48 % |
| Q4 | Feb 9, 2026 | $708.45M | $687.03M | 3.12 % |
| Q3 | Oct 22, 2025 | $659.90M | $640.77M | 2.99 % |